Understanding the patient perspective after ventral hernia repair
- 122 Downloads
More than 350,000 ventral hernia repairs are performed in the U.S. each year. However, long-term quality of life of patients living with hernia repair is less known. Follow-up using patient-reported outcomes (measures) is an important representation of the patient experience and can inform quality improvements of hernia treatments. This study aims to understand the patients’ experience after ventral hernia repair, to enhance quality of care and long-term hernia treatment outcomes.
To better understand long-term outcomes of ventral hernia repair and to enhance an existing PRO tool, two rounds of semi-structured interviews and focus groups were conducted. In total, 22 patients who had ventral hernia repair were enrolled. The patient perspectives obtained were grouped into themes to inform the further development of the PRO tool. Data were transcribed and analyzed using atlas.ti and Microsoft Word.
Ten major themes were identified in this analysis. Patients’ quality of life was impacted by hernia repairs and hernia recurrences, including chronic pain, effects on daily activities and social relationships, and the challenge in finding new treatments. The lack of provider–patient communication and patient understanding of hernia repairs highlighted the need for providing patients with more comprehensive information regarding repair options and outcomes prior to surgery.
PRO assessments and meaningful communications between the physician and the patient can provide a comprehensive benefit–risk assessment prior to surgery, and may also improve patient understanding of what to expect during recovery from surgery.
KeywordsVentral hernia Patient-reported outcomes Hernia repair Quality of life Food Drug Administration
The authors would like to acknowledge Dr. Benjamin Poulose and Dr. Michael Rosen of the Americas Hernia Society Quality Collaborative for their significant contributions to this work.
No funds or support has been received for this work.
Compliance with ethical standards
Conflict of interest
All authors declare no conflict of interest.
Experiments comply with the current laws of the country in which they were performed.
Human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent for participation was obtained before the interviews began.
- 4.Patient Engagement Advisory Committee (2017) FDA executive summary: documents for patient engagement in medical device clinical trials meetingGoogle Scholar
- 5.U.S. Food and Drug Administration (2009) Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Federal RegisterGoogle Scholar
- 7.Americas Hernia Society Quality Collaborative (2016) FAQs. https://www.ahsqc.org/faqs. Accessed Sep 2016
- 8.Leidy NK, Wilcox TK, Jones PW, Murray L, Winnette R, Howard K, Petrillo J, Powers J, Sethi S, Group E-PS (2010) Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health 13(8):965–975. https://doi.org/10.1111/j.1524-4733.2010.00772.x Google Scholar
- 9.Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD (2009) Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value Health 12(8):1075–1083. https://doi.org/10.1111/j.1524-4733.2009.00603.x Google Scholar
- 11.Patrick DLBL, Gwaltney CJ et al (2011) Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a new PRO instrument. Value Health 14:967–977Google Scholar
- 12.U.S. Food and Drug Administration (2018) MedSun: medical product safety network. https://www.fda.gov/MedicalDevices/Safety/MedSunMedicalProductSafetyNetwork/default.htm. Accessed 5 Feb 2018
- 13.Friese S (2017) ATLAS.ti 8 Windows user manual. Scientific Software Development GmbH, Berlin, GermanyGoogle Scholar
- 14.Ha JF (2010) Doctor-patient communication: a review. Ochsner J 10(1):38–43Google Scholar